<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Nucl Med</journal-id><journal-id journal-id-type="iso-abbrev">J Nucl Med</journal-id><journal-id journal-id-type="pmc-domain-id">3060</journal-id><journal-id journal-id-type="pmc-domain">jnucmed</journal-id><journal-id journal-id-type="publisher-id">jnm</journal-id><journal-title-group><journal-title>Journal of Nuclear Medicine</journal-title></journal-title-group><issn pub-type="ppub">0161-5505</issn><issn pub-type="epub">1535-5667</issn><publisher><publisher-name>Society of Nuclear Medicine and Molecular Imaging</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12079752</article-id><article-id pub-id-type="pmcid-ver">PMC12079752.1</article-id><article-id pub-id-type="pmcaid">12079752</article-id><article-id pub-id-type="pmcaiid">12079752</article-id><article-id pub-id-type="pmid">35487563</article-id><article-id pub-id-type="doi">10.2967/jnumed.121.263506</article-id><article-id pub-id-type="publisher-id">263506</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Continuing Education</subject></subj-group></article-categories><title-group><article-title>Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 1: Technical Considerations and Perfusion and Neuronal Imaging</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Stendahl</surname><given-names initials="JC">John C.</given-names></name><xref rid="FN1" ref-type="author-notes">*</xref><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kwan</surname><given-names initials="JM">Jennifer M.</given-names></name><xref rid="FN1" ref-type="author-notes">*</xref><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pucar</surname><given-names initials="D">Darko</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Sadeghi</surname><given-names initials="MM">Mehran M.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><aff id="aff1">
<label>1</label>Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut;</aff><aff id="aff2">
<label>2</label>Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut; and</aff><aff id="aff3">
<label>3</label>Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut</aff><aff>
<bold>Learning Objectives:</bold> On successful completion of this activity, participants should be able to describe (1) key technical considerations pertaining to cardiovascular radiotracer development; (2) basic concepts in cardiac and peripheral perfusion imaging and associated radiotracers; and (3) basic concepts in cardiovascular neuronal imaging and associated radiotracers.<bold>Financial Disclosure:</bold> This work was supported by grants from NIH (R01AG065917 and R01HL138567) and the Department of Veterans Affairs (I0-BX004038). Dr. Pucar is a board member, officer, or trustee for the Society of Nuclear Medicine and Molecular Imaging, a consultant or advisor for Cohere Health, an employee of Yale University, an investigator for the National Institutes of Health, and a meeting participant or lecturer for Telix Pharmaceuticals. Dr. Kwan is a board member, officer, or trustee for the American Physician Scientists Association. Dr. Sadeghi is an inventor on Yale University MMP and fibrosis tracer patent applications, and a member of the Board of Directors of the American Society of Nuclear Cardiology. The authors of this article have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest.<bold>CME Credit:</bold> SNMMI is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing education for physicians. SNMMI designates each <italic toggle="yes">JNM</italic> continuing education article for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity. For CE credit, SAM, and other credit types, participants can access this activity through the SNMMI website (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.snmmilearningcenter.org" ext-link-type="uri">http://www.snmmilearningcenter.org</ext-link>) through May 2025.</aff></contrib-group><author-notes><corresp>For correspondence or reprints, contact Mehran M. Sadeghi (<email>mehran.sadeghi@yale.edu</email>).</corresp><fn id="FN1" fn-type="equal"><label>*</label><p>Contributed equally to this work.</p></fn></author-notes><pub-date pub-type="ppub"><month>5</month><year>2022</year></pub-date><volume>63</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">406393</issue-id><fpage>649</fpage><lpage>658</lpage><history><date date-type="received"><day>14</day><month>11</month><year>2021</year></date><date date-type="rev-recd"><day>22</day><month>2</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>11</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>15</day><month>05</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-05-16 10:25:47.777"><day>16</day><month>05</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2022 by the Society of Nuclear Medicine and Molecular Imaging.</copyright-statement><copyright-year>2022</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jnm121.263506.pdf"/><abstract><p>The development of new radiotracers for PET and SPECT is central to addressing unmet diagnostic needs related to systemwide trends toward molecular characterization and personalized therapies in cardiovascular medicine. In the following 2-part review, we discuss select emerging radiotracers that may help address important unmet diagnostic needs in central areas of cardiovascular medicine, such as heart failure, arrhythmias, valvular disease, atherosclerosis, and thrombosis. Part 1 examines key technical considerations pertaining to cardiovascular radiotracer development and reviews emerging radiotracers for perfusion and neuronal imaging. Highlights of this work include discussions on the development of <sup>18</sup>F-flurpiridaz, an emerging PET perfusion tracer, and the development of <sup>18</sup>F-based radiotracers for cardiovascular neuronal imaging, such as <sup>18</sup>F-flubrobenguane. Part 2 of this review covers emerging radiotracers for the imaging of inflammation, fibrosis, thrombosis, calcification, and cardiac amyloidosis.</p></abstract><kwd-group><kwd>cardiology (basic/technical)</kwd><kwd>cardiology (clinical)</kwd><kwd>molecular imaging</kwd><kwd>inflammation</kwd><kwd>myocardial perfusion imaging</kwd></kwd-group><counts><page-count count="10"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>